Follow the people · Insider
Eric Venker
Eric Venker files insider transactions with the SEC as a president & immunovant ceo of Roivant Sciences (ROIV). We hold 10 disclosed purchases and sales filed since 29 March 2022, 4 of them in the last 90 days.
- Files forROIV
- Disclosed buys and sells10 in all, 4 in the last 90 days
- Last disclosure1 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 25 March 2022 — 28 August 2026President & Immunovant CEO · Roivant Sciences (ROIV)297 Form 4 lines · source: SEC Form 4
- Filed 28 July 2025 — 2 July 2026Chief Executive Officer · Immunovant (IMVT)14 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 200,000 shares of Roivant SciencesSEC Form 41 September 2026Common Shares · traded 28 August 2026 · filed 1 September 2026
- ▼ sold on the open market 166,182 shares of Roivant SciencesSEC Form 41 September 2026Common Shares · traded 28 August 2026 · filed 1 September 2026
- ▼ sold on the open market 33,818 shares of Roivant SciencesSEC Form 41 September 2026Common Shares · traded 28 August 2026 · filed 1 September 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 41 September 2026Stock Option (Right to Buy) · traded 28 August 2026 · filed 1 September 2026
- had shares withheld for tax on 13,909 shares of Roivant SciencesSEC Form 424 August 2026Common Shares · traded 20 August 2026 · filed 24 August 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 429 July 2026Common Shares · traded 27 July 2026 · filed 29 July 2026
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 429 July 2026Common Shares · traded 27 July 2026 · filed 29 July 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 429 July 2026Stock Option (Right to Buy) · traded 27 July 2026 · filed 29 July 2026
- exercised options over 92,188 shares of ImmunovantSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- returned to the issuer 86,629 shares of ImmunovantSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 3,092 shares of ImmunovantSEC Form 46 July 2026Common Stock · traded 2 July 2026 · filed 6 July 2026
- exercised options over 92,188 shares of Immunovant (a derivative holding)SEC Form 46 July 2026Capped Value Appreciation Rights · traded 1 July 2026 · filed 6 July 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 426 June 2026Common Shares · traded 24 June 2026 · filed 26 June 2026
- ▼ sold on the open market 153,766 shares of Roivant SciencesSEC Form 426 June 2026Common Shares · traded 24 June 2026 · filed 26 June 2026
- ▼ sold on the open market 46,234 shares of Roivant SciencesSEC Form 426 June 2026Common Shares · traded 24 June 2026 · filed 26 June 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 426 June 2026Stock Option (Right to Buy) · traded 24 June 2026 · filed 26 June 2026
- had shares withheld for tax on 34,483 shares of Roivant SciencesSEC Form 422 May 2026Common Shares · traded 20 May 2026 · filed 22 May 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 422 May 2026Common Shares · traded 22 May 2026 · filed 22 May 2026
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 422 May 2026Common Shares · traded 22 May 2026 · filed 22 May 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 422 May 2026Stock Option (Right to Buy) · traded 22 May 2026 · filed 22 May 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 422 April 2026Common Shares · traded 20 April 2026 · filed 22 April 2026
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 422 April 2026Common Shares · traded 20 April 2026 · filed 22 April 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 422 April 2026Stock Option (Right to Buy) · traded 20 April 2026 · filed 22 April 2026
- was granted 232,252 shares of ImmunovantSEC Form 49 April 2026Common Stock · traded 7 April 2026 · filed 9 April 2026
- was granted 336,043 shares of Immunovant (a derivative holding)SEC Form 49 April 2026Stock Option (right to buy) · traded 7 April 2026 · filed 9 April 2026
- exercised options over 368,750 shares of ImmunovantSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- returned to the issuer 334,960 shares of ImmunovantSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 12,820 shares of ImmunovantSEC Form 43 April 2026Common Stock · traded 2 April 2026 · filed 3 April 2026
- ▼ sold on the open market 1,409 shares of ImmunovantSEC Form 43 April 2026Common Stock · traded 2 April 2026 · filed 3 April 2026
- exercised options over 368,750 shares of Immunovant (a derivative holding)SEC Form 43 April 2026Capped Value Appreciation Rights · traded 1 April 2026 · filed 3 April 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 419 March 2026Common Shares · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 419 March 2026Common Shares · traded 17 March 2026 · filed 19 March 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 419 March 2026Stock Option (Right to Buy) · traded 17 March 2026 · filed 19 March 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 419 March 2026Stock Option (Right to Buy) · traded 17 March 2026 · filed 19 March 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 419 March 2026Common Shares · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 419 March 2026Common Shares · traded 17 March 2026 · filed 19 March 2026
- had shares withheld for tax on 7,051 shares of Roivant SciencesSEC Form 424 February 2026Common Shares · traded 20 February 2026 · filed 24 February 2026
- had shares withheld for tax on 7,051 shares of Roivant SciencesSEC Form 424 February 2026Common Shares · traded 20 February 2026 · filed 24 February 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 418 February 2026Common Shares · traded 13 February 2026 · filed 18 February 2026
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 418 February 2026Common Shares · traded 13 February 2026 · filed 18 February 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 418 February 2026Stock Option (Right to Buy) · traded 13 February 2026 · filed 18 February 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 418 February 2026Stock Option (Right to Buy) · traded 13 February 2026 · filed 18 February 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 418 February 2026Common Shares · traded 13 February 2026 · filed 18 February 2026
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 418 February 2026Common Shares · traded 13 February 2026 · filed 18 February 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 414 January 2026Common Shares · traded 12 January 2026 · filed 14 January 2026
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 414 January 2026Common Shares · traded 12 January 2026 · filed 14 January 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 414 January 2026Stock Option (Right to Buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 414 January 2026Stock Option (Right to Buy) · traded 12 January 2026 · filed 14 January 2026
- exercised options over 200,000 shares of Roivant SciencesSEC Form 414 January 2026Common Shares · traded 12 January 2026 · filed 14 January 2026
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 414 January 2026Common Shares · traded 12 January 2026 · filed 14 January 2026
- exercised options over 313,841 shares of Roivant Sciences (a derivative holding)SEC Form 429 December 2025Stock Option (Right to Buy) · traded 23 December 2025 · filed 29 December 2025
- exercised options over 117,848 shares of Roivant Sciences (a derivative holding)SEC Form 429 December 2025Stock Option (Right to Buy) · traded 24 December 2025 · filed 29 December 2025
- exercised options over 313,841 shares of Roivant SciencesSEC Form 429 December 2025Common Shares · traded 23 December 2025 · filed 29 December 2025
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 429 December 2025Common Shares · traded 23 December 2025 · filed 29 December 2025
- exercised options over 117,848 shares of Roivant SciencesSEC Form 429 December 2025Common Shares · traded 24 December 2025 · filed 29 December 2025
- ▼ sold on the open market 75,000 shares of Roivant SciencesSEC Form 429 December 2025Common Shares · traded 24 December 2025 · filed 29 December 2025
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 411 December 2025Stock Option (Right to Buy) · traded 9 December 2025 · filed 11 December 2025
- exercised options over 200,000 shares of Roivant SciencesSEC Form 411 December 2025Common Shares · traded 9 December 2025 · filed 11 December 2025
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 411 December 2025Common Shares · traded 9 December 2025 · filed 11 December 2025
- had shares withheld for tax on 7,051 shares of Roivant SciencesSEC Form 424 November 2025Common Shares · traded 20 November 2025 · filed 24 November 2025
- exercised options over 200,000 shares of Roivant Sciences (a derivative holding)SEC Form 47 November 2025Stock Option (Right to Buy) · traded 7 November 2025 · filed 7 November 2025
- exercised options over 200,000 shares of Roivant SciencesSEC Form 47 November 2025Common Shares · traded 7 November 2025 · filed 7 November 2025
- ▼ sold on the open market 200,000 shares of Roivant SciencesSEC Form 47 November 2025Common Shares · traded 7 November 2025 · filed 7 November 2025
- exercised options over 414,683 shares of Roivant Sciences (a derivative holding)SEC Form 417 October 2025Stock Option (Right to Buy) · traded 15 October 2025 · filed 17 October 2025
- exercised options over 318,282 shares of Roivant Sciences (a derivative holding)SEC Form 417 October 2025Stock Option (Right to Buy) · traded 16 October 2025 · filed 17 October 2025
- exercised options over 118,418 shares of Roivant Sciences (a derivative holding)SEC Form 417 October 2025Stock Option (Right to Buy) · traded 17 October 2025 · filed 17 October 2025
- exercised options over 414,683 shares of Roivant SciencesSEC Form 417 October 2025Common Shares · traded 15 October 2025 · filed 17 October 2025
- ▼ sold on the open market 414,683 shares of Roivant SciencesSEC Form 417 October 2025Common Shares · traded 15 October 2025 · filed 17 October 2025
- exercised options over 318,282 shares of Roivant SciencesSEC Form 417 October 2025Common Shares · traded 16 October 2025 · filed 17 October 2025
- ▼ sold on the open market 318,282 shares of Roivant SciencesSEC Form 417 October 2025Common Shares · traded 16 October 2025 · filed 17 October 2025
- exercised options over 118,418 shares of Roivant SciencesSEC Form 417 October 2025Common Shares · traded 17 October 2025 · filed 17 October 2025
- ▼ sold on the open market 118,418 shares of Roivant SciencesSEC Form 417 October 2025Common Shares · traded 17 October 2025 · filed 17 October 2025
- exercised options over 104,940 shares of Roivant Sciences (a derivative holding)SEC Form 414 October 2025Stock Option (Right to Buy) · traded 9 October 2025 · filed 14 October 2025
- exercised options over 20,727 shares of Roivant Sciences (a derivative holding)SEC Form 414 October 2025Stock Option (Right to Buy) · traded 13 October 2025 · filed 14 October 2025
- exercised options over 104,940 shares of Roivant SciencesSEC Form 414 October 2025Common Shares · traded 9 October 2025 · filed 14 October 2025
- ▼ sold on the open market 104,940 shares of Roivant SciencesSEC Form 414 October 2025Common Shares · traded 9 October 2025 · filed 14 October 2025
- exercised options over 20,727 shares of Roivant SciencesSEC Form 414 October 2025Common Shares · traded 13 October 2025 · filed 14 October 2025
- ▼ sold on the open market 20,727 shares of Roivant SciencesSEC Form 414 October 2025Common Shares · traded 13 October 2025 · filed 14 October 2025
- exercised options over 127,355 shares of Roivant Sciences (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 6 October 2025 · filed 8 October 2025
- exercised options over 24,900 shares of Roivant Sciences (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 6 October 2025 · filed 8 October 2025
- exercised options over 19,141 shares of Roivant Sciences (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 6 October 2025 · filed 8 October 2025
- exercised options over 67,171 shares of Roivant Sciences (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 7 October 2025 · filed 8 October 2025
- exercised options over 107,131 shares of Roivant Sciences (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 7 October 2025 · filed 8 October 2025
- exercised options over 180,859 shares of Roivant Sciences (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 7 October 2025 · filed 8 October 2025
- exercised options over 10,307 shares of Roivant Sciences (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 8 October 2025 · filed 8 October 2025
- exercised options over 128,295 shares of Roivant Sciences (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 8 October 2025 · filed 8 October 2025
- exercised options over 127,355 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 6 October 2025 · filed 8 October 2025
- exercised options over 24,900 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 6 October 2025 · filed 8 October 2025
- exercised options over 19,141 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 6 October 2025 · filed 8 October 2025
- ▼ sold on the open market 171,396 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 6 October 2025 · filed 8 October 2025
- exercised options over 67,171 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 7 October 2025 · filed 8 October 2025
- exercised options over 107,131 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 7 October 2025 · filed 8 October 2025
- exercised options over 180,859 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 7 October 2025 · filed 8 October 2025
- ▼ sold on the open market 355,161 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 7 October 2025 · filed 8 October 2025
- exercised options over 10,307 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 8 October 2025 · filed 8 October 2025
- exercised options over 128,295 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 8 October 2025 · filed 8 October 2025
- ▼ sold on the open market 138,602 shares of Roivant SciencesSEC Form 48 October 2025Common Shares · traded 8 October 2025 · filed 8 October 2025
- exercised options over 1,000,000 shares of Roivant Sciences (a derivative holding)SEC Form 423 September 2025Stock Option (Right to Buy) · traded 19 September 2025 · filed 23 September 2025
- exercised options over 462,374 shares of Roivant Sciences (a derivative holding)SEC Form 423 September 2025Stock Option (Right to Buy) · traded 22 September 2025 · filed 23 September 2025
- exercised options over 100,000 shares of Roivant Sciences (a derivative holding)SEC Form 423 September 2025Stock Option (Right to Buy) · traded 22 September 2025 · filed 23 September 2025
- exercised options over 1,000,000 shares of Roivant SciencesSEC Form 423 September 2025Common Shares · traded 19 September 2025 · filed 23 September 2025
- ▼ sold on the open market 683,818 shares of Roivant SciencesSEC Form 423 September 2025Common Shares · traded 19 September 2025 · filed 23 September 2025
- exercised options over 462,374 shares of Roivant SciencesSEC Form 423 September 2025Common Shares · traded 22 September 2025 · filed 23 September 2025
- exercised options over 100,000 shares of Roivant SciencesSEC Form 423 September 2025Common Shares · traded 22 September 2025 · filed 23 September 2025
- ▼ sold on the open market 316,182 shares of Roivant SciencesSEC Form 423 September 2025Common Shares · traded 22 September 2025 · filed 23 September 2025
- ▼ sold on the open market 100,000 shares of Roivant SciencesSEC Form 423 September 2025Common Shares · traded 22 September 2025 · filed 23 September 2025
- ▼ sold on the open market 611,000 shares of Roivant SciencesSEC Form 423 September 2025Common Shares · traded 23 September 2025 · filed 23 September 2025
- exercised options over 100,000 shares of Roivant Sciences (a derivative holding)SEC Form 422 August 2025Stock Option (Right to Buy) · traded 20 August 2025 · filed 22 August 2025
- had shares withheld for tax on 7,051 shares of Roivant SciencesSEC Form 422 August 2025Common Shares · traded 20 August 2025 · filed 22 August 2025
- exercised options over 100,000 shares of Roivant SciencesSEC Form 422 August 2025Common Shares · traded 20 August 2025 · filed 22 August 2025
- ▼ sold on the open market 100,000 shares of Roivant SciencesSEC Form 422 August 2025Common Shares · traded 20 August 2025 · filed 22 August 2025
- was granted 198,413 shares of Roivant SciencesSEC Form 41 August 2025Common Shares · traded 30 July 2025 · filed 1 August 2025
- was granted 1,300,000 shares of Immunovant (a derivative holding)SEC Form 430 July 2025Stock Option (right to buy) · traded 28 July 2025 · filed 30 July 2025
- was granted 189,900 shares of Immunovant (a derivative holding)SEC Form 430 July 2025Stock Option (right to buy) · traded 28 July 2025 · filed 30 July 2025
- was granted 1,475,000 shares of Immunovant (a derivative holding)SEC Form 430 July 2025Capped Value Appreciation Rights · traded 28 July 2025 · filed 30 July 2025
- exercised options over 100,000 shares of Roivant Sciences (a derivative holding)SEC Form 423 July 2025Stock Option (Right to Buy) · traded 21 July 2025 · filed 23 July 2025
- exercised options over 100,000 shares of Roivant SciencesSEC Form 423 July 2025Common Shares · traded 21 July 2025 · filed 23 July 2025
- ▼ sold on the open market 100,000 shares of Roivant SciencesSEC Form 423 July 2025Common Shares · traded 21 July 2025 · filed 23 July 2025
- exercised options over 100,000 shares of Roivant Sciences (a derivative holding)SEC Form 424 June 2025Stock Option (Right to Buy) · traded 20 June 2025 · filed 24 June 2025
- exercised options over 100,000 shares of Roivant SciencesSEC Form 424 June 2025Common Shares · traded 20 June 2025 · filed 24 June 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.